TSLP and Alzheimer disease: Thus, in AD, subclinical inflammation is present even in the non-lesional skin at the initial stages of the disease, characterized by an increased expression of Th2 cytokines (IL-4, IL-13, IL-31, TSLP, IL-5) mediated by Th2 cells and other immune cells.